Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis
Status:
Completed
Trial end date:
2017-07-27
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate the efficacy of vonoprazan (TAK-438) versus
lansoprazole in the treatment of erosive esophagitis classified as Los Angeles (LA)
classification grades A to D at Week 8.